One of the aims is to evaluate the methodological quality of trials in TCM. But evaluation of the use of appropriate TCM methodology was not included. Differentiation of syndromes (bian zheng lun zhi) is central to TCM theory since it uses its own distinct diagnosis and treatment paradigm (especially Chinese herbal medicine) and is arguably the more important determinant for risk of bias in TCM trials. The studies should be scrutinized again to determine if bian zheng lun zhi methodology was applied, and reported upon in the paper. RESULTS & CONCLUSIONS P8, line 29 the breakdown by registry is not shown in table 1 only the TCM specialty.
THE STUDY
One of the aims is to evaluate the methodological quality of trials in TCM. But evaluation of the use of appropriate TCM methodology was not included. Differentiation of syndromes (bian zheng lun zhi) is central to TCM theory since it uses its own distinct diagnosis and treatment paradigm (especially Chinese herbal medicine) and is arguably the more important determinant for risk of bias in TCM trials. The studies should be scrutinized again to determine if bian zheng lun zhi methodology was applied, and reported upon in the paper. RESULTS & CONCLUSIONS P8, line 29 the breakdown by registry is not shown in table 1 
GENERAL COMMENTS
Clinical trials are most important for promoting Chinese medicine in mainstream medicine, and for that, the registry of clinical trials in Chinese medicine is the key way to report the outcomes of those trials. Thus, this is right time to overview the registered clinical trials in Chinese medicine, and the manuscript gives a very good overview in that issue. I would recommend accept for publication with some minor revisions:
1. I don't think it is proper to make the conclusion: we conclude that the quality of reporting of TCM trials is not satisfactory, though there are some inconsistencies with the registered trial protocols. Furthermore, some limitations mentions by the authors in the manuscript also make us more cautious about the conclusion. 2. It would be much better if the authors can make further analysis on those inconsistencies: such as possible correlation with bias, safety and efficacy, by comparing to the previous SR on the topics. Clinical trials are most important for promoting Chinese medicine in mainstream medicine, and for that, the registry of clinical trials in Chinese medicine is the key way to report the outcomes of those trials. Thus, this is right time to overview the registered clinical trials in Chinese medicine, and the manuscript gives a very good overview in that issue. I would recommend accept for publication with some minor revisions:
REVIEWER
1. I don't think it is proper to make the conclusion: we conclude that the quality of reporting of TCM trials is not satisfactory, though there are some inconsistencies with the registered trial protocols. Furthermore, some limitations mentions by the authors in the manuscript also make us more cautious about the conclusion. Response: We agree with the advice, and we revised our conclusions (see last paragraph in the discussion).
2. It would be much better if the authors can make further analysis on those inconsistencies: such as possible correlation with bias, safety and efficacy, by comparing to the previous SR on the topics. Response: Thanks for the constructive suggestions. Due to limited time and data available from original trials, we are not able to do in-depth analyses around the correlation among bias, safety and efficacy. But this would be a good topic for future study.
Reviewer: Phil Wiffen Cochrane Pain , palliative & Supportive Care Group
Methods in the abstract would benefit from more detail within the word limit. I wonder if the overall message is unduly negative. It seems that considerable improvements are being seen in TCM research and publications. Response: Thanks for the suggestions. We have modified the method section in the abstract within the allowed word limit. And the conclusions have been modified to reflect the main message.
The authors don't comment on the lag time between completing a study and the writing for publication, submission and journal processes all of which can be considerable Response: Thanks for this important comment. We now have added some comments in our discussion (see discussion p9, line 6 "The required reporting items for trial registration varied across registries (Table 3) ." Table 3 does not show the variation across registries, only the methodological variation across TCM interventions.
p12,line 54"We conclude that the study design and quality of reporting of TCM trials has improved through prospective international trial registration..". It is unclear how the study design has improved. Is this relating to the studies cited in the background section? If so, this needs elaborating on and citing here. Also, 78% of herbal medicine trials did not report using syndrome differentiation, which implies the majority of patients were, inappropriately treated, and resources wasted on inappropriate trial design. which doesn't appear to indicate in improvement in study quality.
